Singapur - İngilizce - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - amoxycillin trihydrate eqv amoxycillin; potassium clavulanate eqv clavulanic acid - tablet, film coated - 250 mg - amoxycillin trihydrate eqv amoxycillin 250 mg; potassium clavulanate eqv clavulanic acid 125 mg

Singapur - İngilizce - HSA (Health Sciences Authority)

sandoz singapore pte. ltd. - amoxycillin trihydrate eqv amoxycillin; potassium clavulanate eqv clavulanic acid - tablet, film coated - 500 mg - amoxycillin trihydrate eqv amoxycillin 500 mg; potassium clavulanate eqv clavulanic acid 125 mg

Bahreyn - İngilizce - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

al jishi pharmacy - amoxicillin, clavulanic acid - film coated tablet - 625

Bahreyn - İngilizce - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

al jishi pharmacy - amoxicillin, clavulanic acid - film coated tablet - 1

Suudi Arabistan - İngilizce - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sandoz, austria - amoxicillin,clavulanic acid - film-coated tablet - 875,125 mg,

Suudi Arabistan - İngilizce - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sandoz, austria - amoxicillin,clavulanic acid - film-coated tablet - 500,125 mg,

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - amoxicillin trihydrate 28.7 mg/ml equivalent to amoxycillin 25 mg/ml;  ; potassium clavulanate 8.6 mg/ml equivalent to clavulanic acid 6.25 mg/ml (plus 13% overage);  ;   - powder for oral suspension - 125mg,31.25mg/5ml - active: amoxicillin trihydrate 28.7 mg/ml equivalent to amoxycillin 25 mg/ml   potassium clavulanate 8.6 mg/ml equivalent to clavulanic acid 6.25 mg/ml (plus 13% overage)     excipient: aspartame citric acid guar gum hydrated silica lemon flavour 15020598 orange flavour 055301 ap0551 peach-apricot flavour 26f22 purified talc sodium citrate - short term treatment of common bacterial infections such as: upper respiratory tract infections (including ent): e.g. tonsillitis, sinusitis, otitis media lower respiratory tract infections: e.g. acute exacerbations of chronic bronchitis, lobar and broncho-pneumonia genito-urinary tract infections: e.g. cystitis, urethritis, pyelonephritis, female genital infections skin and soft tissue infections bone and joint infections: e.g. osteomyelitis other infections: e.g. septic abortion, puerperal sepsis, intra-abdominal sepsis, septicaemia, peritonitis and post-surgical infections. prophylaxis against infection which may be associated with major surgical procedures such as gastro-intestinal, pelvic, head and neck, cardiac, renal, joint replacement and biliary tract surgery. infections caused by amoxycillin susceptible organisms are amenable to amoxycillin/clavulanic acid treatment due to its amoxycillin content. mixed infections caused by amoxycillin susceptible organisms in conjunction with amoxycillin/clavulanic acid susceptible beta-lactamase-producing organisms may therefore be treated by amoxycillin/clavulanic acid.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - amoxicillin trihydrate 57.4 mg/ml equivalent to amoxycillin 50 mg/ml;  ; potassium clavulanate 17.2 mg/ml equivalent to clavulanic acid 12.5 mg/ml (pius 13% overage);  ;   - powder for oral suspension - 250mg, 62.5mg/5ml - active: amoxicillin trihydrate 57.4 mg/ml equivalent to amoxycillin 50 mg/ml   potassium clavulanate 17.2 mg/ml equivalent to clavulanic acid 12.5 mg/ml (pius 13% overage)     excipient: aspartame citric acid guar gum hydrated silica lemon flavour 15020598 orange flavour 055301 ap0551 peach-apricot flavour 26f22 purified talc sodium citrate - short term treatment of common bacterial infections such as: upper respiratory tract infections (including ent): e.g. tonsillitis, sinusitis, otitis media lower respiratory tract infections: e.g. acute exacerbations of chronic bronchitis, lobar and broncho-pneumonia genito-urinary tract infections: e.g. cystitis, urethritis, pyelonephritis, female genital infections skin and soft tissue infections bone and joint infections: e.g. osteomyelitis other infections: e.g. septic abortion, puerperal sepsis, intra-abdominal sepsis, septicaemia, peritonitis and post-surgical infections. prophylaxis against infection which may be associated with major surgical procedures such as gastro-intestinal, pelvic, head and neck, cardiac, renal, joint replacement and biliary tract surgery. infections caused by amoxycillin susceptible organisms are amenable to amoxycillin/clavulanic acid treatment due to its amoxycillin content. mixed infections caused by amoxycillin susceptible organisms in conjunction with amoxycillin/clavulanic acid susceptible beta-lactamase-producing organisms may therefore be treated by amoxycillin/clavulanic acid.

Uganda - İngilizce - National Drug Authority

novartis pharma services inc - amoxicillin + clavulanic acid - oral solid ordinary film-coated tablets - 875 mg + 125 mg

Uganda - İngilizce - National Drug Authority

sandoz kenya c/o novartis pharma services inc - amoxycillin + potassium clavulanate - oral solid ordinary film-coated tablets - 500mg+125mg